These results demonstrated that TNFSF13 expression was upregulated in macrophage activation, T-cell-related signaling transduction, and antigen-presenting cells, while negatively associated with B-lymphocyte-related metagenes during immunosuppression in the progression of gliomas. This evidence concerns the gene TNFSF13 and central nervous system cancer.